Motus GI Holdings announced that it will effect a 1-for-15 reverse stock split of its outstanding common stock. The Company’s common stock will begin trading on a split-adjusted basis at the opening of the market on Thursday, November 2, 2023. The Company’s common stock will continue to trade on the Nasdaq Capital Market under the symbol “MOTS” and under the new CUSIP number: 62014P504. The reverse stock split is intended to increase the per share trading price of Motus GI’s common stock to satisfy the $1.00 minimum bid price requirement for continued listing on the Nasdaq Capital Market.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on MOTS:
- Motus receives FDA clearance to commercialize Pure-Vu EVS Gastro, Gen 4 Colon
- Motus GI Holdings files to sell common stock, no amount given
- Motus GI Holdings submits special 510k to FDA for Pure-Vu EVS
- Motus GI Submits Special 510(k) to FDA for Pure-Vu EVS Gen 4 Gastro and Colon
- Motus GI Amends Royalty Agreement